Found: 105
Select item for more details and to access through your institution.
A phase I-II design based on periodic and continuous monitoring of disease status and the times to toxicity and death.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A decision-theoretic phase I-II design for ordinal outcomes in two cycles.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Bayesian feature allocation model for identifying cell subpopulations using CyTOF data.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2023, v. 72, n. 3, p. 718, doi. 10.1093/jrsssc/qlad029
- By:
- Publication type:
- Article
Utility‐based Bayesian personalized treatment selection for advanced breast cancer.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2022, v. 71, n. 5, p. 1605, doi. 10.1111/rssc.12582
- By:
- Publication type:
- Article
Bayesian non‐parametric survival regression for optimizing precision dosing of intravenous busulfan in allogeneic stem cell transplantation.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 3, p. 809, doi. 10.1111/rssc.12331
- By:
- Publication type:
- Article
Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 2, p. 461, doi. 10.1111/rssc.12271
- By:
- Publication type:
- Article
Parametric dose standardization for optimizing two-agent combinations in a phase I-II trial with ordinal outcomes.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2017, v. 66, n. 1, p. 201, doi. 10.1111/rssc.12162
- By:
- Publication type:
- Article
Bayesian group sequential clinical trial design using total toxicity burden and progression-free survival.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2016, v. 65, n. 2, p. 273, doi. 10.1111/rssc.12117
- By:
- Publication type:
- Article
Evaluating joint effects of induction-salvage treatment regimes on overall survival in acute leukaemia.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2013, v. 62, n. 1, p. 67, doi. 10.1111/j.1467-9876.2012.01048.x
- By:
- Publication type:
- Article
Estimating progression-free survival in paediatric brain tumour patients when some progression statuses are unknown.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2012, v. 61, n. 1, p. 135, doi. 10.1111/j.1467-9876.2011.01002.x
- By:
- Publication type:
- Article
A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2010, v. 59, n. 1, p. 19, doi. 10.1111/j.1467-9876.2009.00680.x
- By:
- Publication type:
- Article
Estimating Genomic Category Probabilities from Fluorescent in Situ Hybridization Counts with Misclassification.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 1996, v. 45, n. 4, p. 431, doi. 10.2307/2986066
- By:
- Publication type:
- Article
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 641, p. 1, doi. 10.1126/scitranslmed.abm6420
- By:
- Publication type:
- Article
Interpreting Randomized Controlled Trials.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4674, doi. 10.3390/cancers15194674
- By:
- Publication type:
- Article
A Causal Framework for Making Individualized Treatment Decisions in Oncology.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3923, doi. 10.3390/cancers14163923
- By:
- Publication type:
- Article
Making Patient-Specific Treatment Decisions Using Prognostic Variables and Utilities of Clinical Outcomes.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2741, doi. 10.3390/cancers13112741
- By:
- Publication type:
- Article
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3251, doi. 10.3390/cancers12113251
- By:
- Publication type:
- Article
Precision Bayesian phase I‐II dose‐finding based on utilities tailored to prognostic subgroups.
- Published in:
- Statistics in Medicine, 2021, v. 40, n. 24, p. 5199, doi. 10.1002/sim.9120
- By:
- Publication type:
- Article
A review of phase 2-3 clinical trial designs.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Generalized phase I‐II designs to increase long term therapeutic success rate.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 4, p. 692, doi. 10.1002/pst.2301
- By:
- Publication type:
- Article
A Bayesian piecewise exponential phase II design for monitoring a time‐to‐event endpoint.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 1, p. 34, doi. 10.1002/pst.2256
- By:
- Publication type:
- Article
Comparing Bayesian early stopping boundaries for phase II clinical trials.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 928, doi. 10.1002/pst.2046
- By:
- Publication type:
- Article
Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination.
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 6, p. 734, doi. 10.1002/pst.1891
- By:
- Publication type:
- Article
Bayesian nonparametric statistics: A new toolkit for discovery in cancer research.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 6, p. 414, doi. 10.1002/pst.1819
- By:
- Publication type:
- Article
A simulation study of methods for selecting subgroup-specific doses in phase 1 trials.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 143, doi. 10.1002/pst.1797
- By:
- Publication type:
- Article
Ethical issues in oncology biostatistics.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 9, p. 2507, doi. 10.1002/cncr.26517
- By:
- Publication type:
- Article
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Maintenance Therapy With Low-Dose Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for Recurrent Acute Myelogenous Leukemia or Myelodysplastic Syndrome.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 23, p. 5420, doi. 10.1002/cncr.25500
- By:
- Publication type:
- Article
A Possible Association Between Aprotinin and Improved Survival After Radical Surgery for Mesothelioma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 4, p. 833, doi. 10.1002/cncr.24108
- By:
- Publication type:
- Article
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies.
- Published in:
- Prostate, 2007, v. 67, n. 15, p. 1677, doi. 10.1002/pros.20649
- By:
- Publication type:
- Article
Robust Adaptive Incorporation of Historical Control Data in a Randomized Trial of External Cooling to Treat Septic Shock.
- Published in:
- Bayesian Analysis, 2021, v. 16, n. 3, p. 825, doi. 10.1214/20-BA1229
- By:
- Publication type:
- Article
A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes.
- Published in:
- Bayesian Analysis, 2021, v. 16, n. 1, p. 179, doi. 10.1214/20-BA1205
- By:
- Publication type:
- Article
A Decision-Theoretic Comparison of Treatments to Resolve Air Leaks After Lung Surgery Based on Nonparametric Modeling.
- Published in:
- Bayesian Analysis, 2017, v. 12, n. 3, p. 639, doi. 10.1214/16-BA1016
- By:
- Publication type:
- Article
Selenium and Vitamin E: Cell Type- and Intervention-Specific Tissue Effects in Prostate Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 5, p. 306, doi. 10.1093/jnci/djn512
- By:
- Publication type:
- Article
Response.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Adaptive Therapy for Androgen-Independent Prostate Cancer: A Randomized Selection Trial of Four Regimens.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 21, p. 1613, doi. 10.1093/jnci/djm189
- By:
- Publication type:
- Article
Clinical trial design as a decision problem.
- Published in:
- Applied Stochastic Models in Business & Industry, 2017, v. 33, n. 3, p. 296, doi. 10.1002/asmb.2222
- By:
- Publication type:
- Article
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison.
- Published in:
- Biometrics, 2024, v. 80, n. 1, p. 1, doi. 10.1093/biomtc/ujad022
- By:
- Publication type:
- Article
Bayesian treatment screening and selection using subgroup‐specific utilities of response and toxicity.
- Published in:
- Biometrics, 2023, v. 79, n. 3, p. 2458, doi. 10.1111/biom.13738
- By:
- Publication type:
- Article
Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers.
- Published in:
- Biometrics, 2022, v. 78, n. 1, p. 60, doi. 10.1111/biom.13421
- By:
- Publication type:
- Article
An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes.
- Published in:
- Biometrics, 2020, v. 76, n. 1, p. 304, doi. 10.1111/biom.13116
- By:
- Publication type:
- Article
A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III.
- Published in:
- Biometrics, 2019, v. 75, n. 2, p. 371, doi. 10.1111/biom.12994
- By:
- Publication type:
- Article
Rejoinder to "A hybrid phase I‐II/III clinical trial design allowing dose reoptimization in phase III".
- Published in:
- Biometrics, 2019, v. 75, n. 2, p. 389, doi. 10.1111/biom.12991
- By:
- Publication type:
- Article
A utility‐based design for randomized comparative trials with ordinal outcomes and prognostic subgroups.
- Published in:
- Biometrics, 2018, v. 74, n. 3, p. 1095, doi. 10.1111/biom.12842
- By:
- Publication type:
- Article
Bayesian nonparametric estimation of targeted agent effects on biomarker change to predict clinical outcome.
- Published in:
- Biometrics, 2015, v. 71, n. 1, p. 188, doi. 10.1111/biom.12250
- By:
- Publication type:
- Article
Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule-Dose Regimes.
- Published in:
- Biometrics, 2013, v. 69, n. 3, p. 673, doi. 10.1111/biom.12065
- By:
- Publication type:
- Article
Optimizing the Concentration and Bolus of a Drug Delivered by Continuous Infusion.
- Published in:
- Biometrics, 2011, v. 67, n. 4, p. 1638, doi. 10.1111/j.1541-0420.2011.01580.x
- By:
- Publication type:
- Article